Longhua Chinese medicine最新文献_第9页

Acupuncture: an integrative therapy for pain management and opioid reduction in the United States 针灸:美国疼痛管理和阿片类药物减少的综合疗法

Longhua Chinese medicine Pub Date : 2019-12-12 DOI: 10.21037/LCM.2019.09.05

A. Fan, S. Alemi

引用次数: 1

Diabetic gastroparesis: what can complementary and alternative medicines do? 糖尿病性胃轻瘫:补充和替代药物能做什么?

Longhua Chinese medicine Pub Date : 2019-12-01 DOI: 10.21037/lcm.2019.11.01

Shi-Yi Liu, Ying-pan Zhao, Ning Zhang

{"title":"Diabetic gastroparesis: what can complementary and alternative medicines do?","authors":"Shi-Yi Liu, Ying-pan Zhao, Ning Zhang","doi":"10.21037/lcm.2019.11.01","DOIUrl":"https://doi.org/10.21037/lcm.2019.11.01","url":null,"abstract":"Diabetic gastroparesis (DGP) is a complication of long-standing diabetes mellitus (DM) and a chronic motility disorder of the stomach. Up to 50% of patients with type 1 and 2 DM have the gastrointestinal manifestations, especially delayed gastric emptying (GE). And DM accounted for almost one-third of all cases of gastroparesis. The most common symptoms of DGP include postprandial fullness, early satiety, nausea, vomiting, bloating, and abdominal pain, which markedly lead to poor quality of life. Therapeutic strategies in western medicine for DGP involve dietary modification, the control of blood glucose, medications that stimulate gastric motor activity, anti-emetic and prokinetic drug therapy, and nonpharmacological measures. However, the limited effectiveness and the side effects of the strategies above mentioned may be restricted for their applications sometimes. Complementary and alternative therapy like Chinese herbs, acupuncture, moxibustion, and massage has been widely used for thousands of years and there are an increasing number of studies in DGP about them, suggesting that Chinese medicine could bring multiple benefits in the treatment of refractory nausea and vomiting and also help to alleviate abdominal distension with fewer side effects. Here, we focus on the general treatment strategies of complementary and alternative therapy, as discovered through PubMed and CNKI in English and Chinese publications, respectively.","PeriodicalId":74086,"journal":{"name":"Longhua Chinese medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/lcm.2019.11.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47738791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Qingdai ointment in the treatment of plaque psoriasis: a case report 青带软膏治疗斑块型银屑病1例

Longhua Chinese medicine Pub Date : 2019-11-22 DOI: 10.21037/lcm.2019.09.03

Shangpu Gao, Wei-Song Kong, Xin Zhou

引用次数: 0

Application of the CARE guideline as reporting standard in the Longhua Chinese Medicine CARE指南在龙华中医报告标准中的应用

Longhua Chinese medicine Pub Date : 2019-11-01 DOI: 10.21037/lcm.2019.10.01

引用次数: 0

Advanced research validates classical principles—the neurobiological mechanisms involved in acupuncture for pain management 先进的研究验证了经典原理——针灸治疗疼痛的神经生物学机制

Longhua Chinese medicine Pub Date : 2019-11-01 DOI: 10.21037/lcm.2019.10.02

Chang-zhen Gong, Wei Liu

引用次数: 2

The new revolution of immunotherapy: is it time to pair it with the old one? —Yellow Leader as a candidate 免疫疗法的新革命：是时候把它和旧的结合起来了吗--黄色领导人作为候选人

Longhua Chinese medicine Pub Date : 2019-10-06 DOI: 10.21037/LCM.2019.05.01

N. Charles

{"title":"The new revolution of immunotherapy: is it time to pair it with the old one? —Yellow Leader as a candidate","authors":"N. Charles","doi":"10.21037/LCM.2019.05.01","DOIUrl":"https://doi.org/10.21037/LCM.2019.05.01","url":null,"abstract":"With the advent of immunotherapy in cancer treatment, the natural history of this disease has changed. The immune checkpoint therapies have shown great promise in this setting, by potentiating the body’s natural immune response against tumor cells. Checkpoint inhibitors (CPIs) have definitively consolidated the target of reversing the immunoevasion as one of the most universal strategies to change the natural evolution of advanced oncological diseases, and to maximize CPI treatment efficacy, synergies in immune system modulation must be seriously considered. In the field of Integrative Oncology, Chinese medicinal mushrooms have been increasingly promoted as excellent anticancer immunoenhancers. However, many plants of traditional Chinese medicine have been less visible, but—as scientific literature reveals—not less powerful as antitumor immunomodulators. Astragalus membranaceous root is a venerated plant as a tonic in traditional Chinese pharmacopoeia. This is known to be beneficial to relieve mild disorders and to help in more serious diseases, such as cancer. For this great restorative capacity was why it won the name of Huang Qi, “leader of all tonics”, or Yellow Leader, because of its colour. Astragalus root contains a variety of immunoactive constituents. Its power as an antitumor root is not only due to its immunomodulatory activity; it is able to modulate several apoptotic and antiangiogenic signaling pathways and interact with specific transcription molecules. We propose a rational model of the combination of CPI with Astragalus root chosen as representative of traditional immunotherapy, to set a paradigmatic frame to develop novel target-specific combinations with natural immunomodulators. We are convinced that by combining these two strategies in immunotherapy—the new one and the old one—we can definitely overcome immune cell exhaustion, boost the response to immunocheckpoint treatment, and minimize side effects, to get better and more efficient results in cancer immunotherapy.","PeriodicalId":74086,"journal":{"name":"Longhua Chinese medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/LCM.2019.05.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47032009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Study on the effect of spleen deficiency on the pathogenesis of psoriasis based on intestinal microbiome 从肠道微生物组研究脾虚对银屑病发病机制的影响

Longhua Chinese medicine Pub Date : 2019-09-30 DOI: 10.21037/lcm.2019.09.02

Ting‐ting Di, Yan Wang, Jingxia Zhao, X. Guo, Zhaoxia Chen, Chunyan Zhai, Ping Li

引用次数: 1

Traditional Japanese medicine in geriatrics, evidences and the guideline 中医药在老年医学中的应用、证据与指南

Longhua Chinese medicine Pub Date : 2019-09-19 DOI: 10.21037/lcm.2019.09.01

K. Iwasaki

引用次数: 0

Treatment of gastroesophageal reflux disease-related chronic cough with lung-stomach co-treatment and nourishing-dampness dual-use 肺胃合治养湿两用治疗胃食管反流病相关慢性咳嗽

Longhua Chinese medicine Pub Date : 2019-09-09 DOI: 10.21037/lcm.2019.08.02

Suxian Zhang, Tiansong Zhang

引用次数: 0

Acupuncture in the treatment of fibromyalgia: what has changed in the last 10 years? 针灸治疗纤维肌痛:在过去的10年里发生了什么变化?

Longhua Chinese medicine Pub Date : 2019-09-08 DOI: 10.21037/LCM.2019.08.01

André Luis Hokama, T. Abe, J. B. G. Silva

{"title":"Acupuncture in the treatment of fibromyalgia: what has changed in the last 10 years?","authors":"André Luis Hokama, T. Abe, J. B. G. Silva","doi":"10.21037/LCM.2019.08.01","DOIUrl":"https://doi.org/10.21037/LCM.2019.08.01","url":null,"abstract":"In the last 10 years, fibromyalgia diagnosis has been transformed by the American College of Rheumatology (ACR) classification criteria. These changes have significantly impacted outcomes in treatment recommendations, including many non-pharmacological therapies, notably acupuncture. This review presents what has changed on acupuncture recommendations for the treatment of fibromyalgia after alterations performed by ACR classification criteria. A literature search was performed to identify published studies between January 01, 2008 and June 30, 2018. Published studies were identified using an initial search of PubMed database. We searched for trials published using the terms “fibromyalgia acupuncture”. We used only full-text articles available online and related to the objective of this review. The last ACR’s criteria [2010] have included the evaluation of other symptoms of fibromyalgia besides pain. New diagnostic and therapeutic technologies have also enabled the publishing of new trials, scientifically demonstrating the effectiveness of acupuncture in patients with the fibromyalgia syndrome. It is concluded that acupuncture is currently considered a scientifically recommended treatment for fibromyalgia.","PeriodicalId":74086,"journal":{"name":"Longhua Chinese medicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.21037/LCM.2019.08.01","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48548749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0